glp 1 molecule The Science Behind the Quest for a Non-Peptide Oral Weight Loss Drug | Office for Science and Society Full-length human GLP-1 receptor structure
Description
Weeks 9 through 12: escalation to 7.5mg If 5mg is tolerated well but results plateau, the next step is 7.5mg
Side Effects and Tolerability The most common side effects are gastrointestinal: Nausea: Affects 20-40% of patients, usually most prominent during dose increases and improving over weeks
Caron J, Domenger D, Dhulster P, Ravallec R, Cudennec B
For appropriate patients, GLP-1 therapy may be one powerful tool in a larger plan to reduce weight-related risk and support better long-term health
How we eat matters too
Orforgliprons safety profile was consistent with injectable GLP-1 therapies
